vs
loanDepot, Inc.（LDI）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
loanDepot, Inc.的季度营收约是REPLIGEN CORP的1.6倍（$310.3M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -7.2%，领先14.0%），loanDepot, Inc.同比增速更快（20.5% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $-648.0M），过去两年loanDepot, Inc.的营收复合增速更高（18.0% vs 14.4%）
loanDepot, Inc.是一家总部位于美国加利福尼亚州欧文市的非银行控股公司，主营抵押贷款及其他非抵押类贷款产品的销售业务，是美国市场上颇具规模的消费信贷服务提供商。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
LDI vs RGEN — 直观对比
营收规模更大
LDI
是对方的1.6倍
$197.9M
营收增速更快
LDI
高出6.9%
13.6%
净利率更高
RGEN
高出14.0%
-7.2%
自由现金流更多
RGEN
多$665.5M
$-648.0M
两年增速更快
LDI
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $310.3M | $197.9M |
| 净利润 | $-22.5M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -10.3% | 9.0% |
| 净利率 | -7.2% | 6.7% |
| 营收同比 | 20.5% | 13.6% |
| 净利润同比 | 32.4% | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LDIRGEN
| Q4 25 | $310.3M | $197.9M | ||
| Q3 25 | $323.3M | $188.8M | ||
| Q2 25 | $282.5M | $182.4M | ||
| Q1 25 | $273.6M | $169.2M | ||
| Q4 24 | $257.5M | $174.1M | ||
| Q3 24 | $314.6M | $154.9M | ||
| Q2 24 | $265.4M | $154.1M | ||
| Q1 24 | $222.8M | $151.3M |
净利润LDIRGEN
| Q4 25 | $-22.5M | $13.3M | ||
| Q3 25 | $-4.9M | $14.9M | ||
| Q2 25 | $-13.4M | $14.9M | ||
| Q1 25 | $-21.9M | $5.8M | ||
| Q4 24 | $-33.2M | $-30.3M | ||
| Q3 24 | $1.4M | $-654.0K | ||
| Q2 24 | $-32.2M | $3.3M | ||
| Q1 24 | $-34.3M | $2.1M |
毛利率LDIRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率LDIRGEN
| Q4 25 | -10.3% | 9.0% | ||
| Q3 25 | -3.2% | 8.9% | ||
| Q2 25 | -11.4% | 7.6% | ||
| Q1 25 | -16.8% | 3.9% | ||
| Q4 24 | -32.7% | -17.7% | ||
| Q3 24 | 1.1% | -5.1% | ||
| Q2 24 | -29.1% | 1.0% | ||
| Q1 24 | -38.2% | 1.3% |
净利率LDIRGEN
| Q4 25 | -7.2% | 6.7% | ||
| Q3 25 | -1.5% | 7.9% | ||
| Q2 25 | -4.7% | 8.2% | ||
| Q1 25 | -8.0% | 3.4% | ||
| Q4 24 | -12.9% | -17.4% | ||
| Q3 24 | 0.4% | -0.4% | ||
| Q2 24 | -12.1% | 2.2% | ||
| Q1 24 | -15.4% | 1.4% |
每股收益（稀释后）LDIRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | $0.01 | $-0.01 | ||
| Q2 24 | $-0.18 | $0.06 | ||
| Q1 24 | $-0.19 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $337.2M | $767.6M |
| 总债务越低越好 | $2.1B | $542.2M |
| 股东权益账面价值 | $386.0M | $2.1B |
| 总资产 | $6.9B | $2.9B |
| 负债/权益比越低杠杆越低 | 5.44× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资LDIRGEN
| Q4 25 | $337.2M | $767.6M | ||
| Q3 25 | $459.2M | $748.7M | ||
| Q2 25 | $408.6M | $708.9M | ||
| Q1 25 | $371.5M | $697.2M | ||
| Q4 24 | $421.6M | $757.4M | ||
| Q3 24 | $483.0M | $784.0M | ||
| Q2 24 | $533.2M | $809.1M | ||
| Q1 24 | $603.7M | $780.6M |
总债务LDIRGEN
| Q4 25 | $2.1B | $542.2M | ||
| Q3 25 | $2.1B | $537.9M | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | $525.6M | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.3B | — |
股东权益LDIRGEN
| Q4 25 | $386.0M | $2.1B | ||
| Q3 25 | $433.3M | $2.1B | ||
| Q2 25 | $439.1M | $2.1B | ||
| Q1 25 | $469.3M | $2.0B | ||
| Q4 24 | $506.6M | $2.0B | ||
| Q3 24 | $592.0M | $2.0B | ||
| Q2 24 | $578.9M | $2.0B | ||
| Q1 24 | $637.3M | $2.0B |
总资产LDIRGEN
| Q4 25 | $6.9B | $2.9B | ||
| Q3 25 | $6.2B | $2.9B | ||
| Q2 25 | $6.2B | $2.9B | ||
| Q1 25 | $6.4B | $2.9B | ||
| Q4 24 | $6.3B | $2.8B | ||
| Q3 24 | $6.4B | $2.8B | ||
| Q2 24 | $5.9B | $2.9B | ||
| Q1 24 | $6.2B | $2.8B |
负债/权益比LDIRGEN
| Q4 25 | 5.44× | 0.26× | ||
| Q3 25 | 4.83× | 0.26× | ||
| Q2 25 | 4.70× | — | ||
| Q1 25 | 4.30× | — | ||
| Q4 24 | 4.00× | 0.27× | ||
| Q3 24 | 3.31× | — | ||
| Q2 24 | 3.41× | — | ||
| Q1 24 | 3.63× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-638.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-648.0M | $17.6M |
| 自由现金流率自由现金流/营收 | -208.9% | 8.9% |
| 资本支出强度资本支出/营收 | 3.0% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-734.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流LDIRGEN
| Q4 25 | $-638.7M | $25.7M | ||
| Q3 25 | $43.4M | $48.1M | ||
| Q2 25 | $67.6M | $28.6M | ||
| Q1 25 | $-179.9M | $15.0M | ||
| Q4 24 | $47.7M | $39.2M | ||
| Q3 24 | $-349.2M | $49.3M | ||
| Q2 24 | $-278.3M | $42.2M | ||
| Q1 24 | $-278.5M | $44.7M |
自由现金流LDIRGEN
| Q4 25 | $-648.0M | $17.6M | ||
| Q3 25 | $38.7M | $43.4M | ||
| Q2 25 | $61.4M | $21.5M | ||
| Q1 25 | $-186.7M | $11.4M | ||
| Q4 24 | $40.8M | $33.6M | ||
| Q3 24 | $-356.4M | $42.3M | ||
| Q2 24 | $-285.7M | $37.4M | ||
| Q1 24 | $-283.3M | $36.4M |
自由现金流率LDIRGEN
| Q4 25 | -208.9% | 8.9% | ||
| Q3 25 | 12.0% | 23.0% | ||
| Q2 25 | 21.7% | 11.8% | ||
| Q1 25 | -68.2% | 6.8% | ||
| Q4 24 | 15.8% | 19.3% | ||
| Q3 24 | -113.3% | 27.3% | ||
| Q2 24 | -107.7% | 24.3% | ||
| Q1 24 | -127.2% | 24.0% |
资本支出强度LDIRGEN
| Q4 25 | 3.0% | 4.1% | ||
| Q3 25 | 1.5% | 2.5% | ||
| Q2 25 | 2.2% | 3.9% | ||
| Q1 25 | 2.5% | 2.1% | ||
| Q4 24 | 2.7% | 3.2% | ||
| Q3 24 | 2.3% | 4.5% | ||
| Q2 24 | 2.8% | 3.1% | ||
| Q1 24 | 2.1% | 5.5% |
现金转化率LDIRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | -255.05× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
